|
|
Volumn 14, Issue 2, 2008, Pages 122-124
|
|
Prior bisphosphonate therapy of osteoporosis attenuates and blocks response to subsequent parathyroid hormone
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
CALCIUM;
PAMIDRONIC ACID;
PARATHYROID HORMONE[1-34];
RALOXIFENE;
RISEDRONIC ACID;
VITAMIN D;
ZOLEDRONIC ACID;
ARTICLE;
BONE DENSITY;
BONE REMODELING;
DRUG ANTAGONISM;
DRUG COST;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
HORMONE SUBSTITUTION;
HUMAN;
OSTEOLYSIS;
OSTEOPOROSIS;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
TRABECULAR BONE;
TREATMENT RESPONSE;
VITAMIN SUPPLEMENTATION;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
COHORT STUDIES;
DIPHOSPHONATES;
DRUG INCOMPATIBILITY;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
OSTEOPOROSIS;
RETROSPECTIVE STUDIES;
TERIPARATIDE;
TREATMENT FAILURE;
|
|
EID: 42049107377
PISSN: 10761608
EISSN: None
Source Type: Journal
DOI: 10.1097/RHU.0b013e31816d84b8 Document Type: Article |
|
Times cited : (5)
|
|
References (5)
|
